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Objectives: Antibacterial drugs (hereafter referred to as antibiotics) are crucial to treat infections during delivery
and postpartum period to reduce maternal mortality. Institutional deliveries have the potential to save lives of many
women but extensive use of antibiotics, add to the development and spread of antibiotic resistance. The aim of this
study was to present antibiotic prescribing among inpatients during and after delivery in a non-teaching, tertiary care
hospital in the city of Ujjain, Madhya Pradesh, India.
Methods: A prospective cross-sectional study was conducted including women having had either a vaginal delivery or
a cesarean section in the hospital. Trained nursing staff collected the data on daily bases, using a specific form attached
to each patient file. Statistical analysis, including bivariate and multivariable logistic regression was conducted.
Results: Of the total 1077 women, 566 (53%) had a vaginal delivery and 511 (47%) had a cesarean section.
Eighty-seven percent of the women that had a vaginal delivery and 98% of the women having a cesarean section
were prescribed antibiotics. The mean number of days on antibiotics in hospital for the women with a vaginal delivery
was 3.1 (±1.7) and for the women with cesarean section was 6.0 (±2.5). Twenty-eight percent of both the women with
vaginal deliveries and the women with cesarean sections were prescribed antibiotics at discharge. The most commonly
prescribed antibiotic group in the hospital for both the women that had a vaginal delivery and the women that had a
cesarean section were third-generation cephalosporins (J01DD). The total number of defined daily doses (DDD) per100
bed days for women that had a vaginal delivery was 101, and 127 for women that had a cesarean section.
Conclusions: The high percentage of women having had a vaginal delivery that received antibiotics and the deviation
from recommendation for cesarean section in the hospital is a cause of concern. Improved maternal health and
rational use of antibiotics are intertwined. Specific policy and guidelines on how to prescribe antibiotics during delivery
at health care facilities are needed. Additionally, monitoring system of antibiotic prescribing and resistance needs to be
developed and implemented.
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The availability of antibacterial drugs (hereafter referred
to as antibiotics) to treat infections during delivery and
postpartum period is crucial to reduce maternal mortal-
ity. Each year some estimated 350 000 maternal deaths
occur worldwide. One of the leading causes of maternal
mortality is the infections [1,2]. Infections are estimated
by the WHO to be the direct cause of 15% of the global
maternal mortality [3], other studies have estimated in-
fections to be the cause of death in as many as 30% of
the global maternal mortality cases [4]. The nation-wide
Maternal mortality rate (MMR) in India dropped sub-
stantially from 570 to 230 per 100 000 live births be-
tween 1990 and 2008. However, the overall average pace
of the decline in MMR indicates that India will not reach
the Millennium Development Goal (MDG) of 108 in
2015 [5]. Recent estimates predicts the MMR will be
around 135 by 2015 [2]. A majority of all maternal
deaths worldwide occur during delivery and the postna-
tal period. One of the single most important interven-
tions to reduce maternal mortality is to increase the
access to emergency obstetric care [6], which in many
cases are dependent on access to antibiotics.
Preventing maternal deaths caused by infections calls
for increased access to health care interventions, includ-
ing access to antibiotics [6]. However, the emerging chal-
lenge of antibiotic resistance also calls for precaution on
how and when antibiotics are prescribed [7]. In India,
there is a widespread use of antibiotics due to both anti-
biotics being easily available without a prescription and
high prescribing rates among health practitioners. Stud-
ies conducted at primary and secondary health care fa-
cilities in India have shown higher rates of antibiotic
prescribing [8-10]. Prescription rates of antibiotics dur-
ing and after delivery are not well known in the Indian
context but there are likely to be cases of both over- and
under prescribing.
The aim of this study was to present the prevalence,
types and duration of antibiotic prescribed to women
during and after vaginal delivery or caesarean section in




Ujjain is situated in Madhya Pradesh, which is one of
the larger states of India, both in terms of geographical
area and in terms of the size of the population. Maternal
health indictors for Madhya Pradesh are among the
poorest in India. Data from the district level household
and family survey conducted in 2007–2008 show that
47% of deliveries take place at a health facility, ranging
from 13% in Dindori district to 79% in Indore district
[11]. Sixty-six percent of the women in Madhya Pradeshhad experienced at least one complication during deliv-
ery, and 41% had experienced post-delivery complica-
tions including high fever and abdominal pain [10]. In
Ujjain district, where data for this study was collected,
90% of the women were covered with antenatal care and
68% of the women had an institutional delivery [11].
There is no general surveillance system to monitor anti-
biotic prescribing or antibiotic resistance in Madhya Pra-
desh. However, studies conducted in Madhya Pradesh
[9] and in Ujjain district [12-14] have shown overall high
prescribing rates among both outpatients and admitted
patients. Neither antibiotic prescribing guidelines in gen-
eral nor specific guidelines for prescribing of antibiotics
during vaginal delivery or for obstetric surgery were
available at the hospital at the time of the study.
Data collection
This study was conducted using a prospective cross-
sectional design, with data collection from April 2008 to
December 2010 at the VD Gardi Charitable Trust Hos-
pital and Research Centre. The hospital is a non-
teaching hospital with 350 beds, located in the city of
Ujjain and run by the Ujjain Charitable Trust, a non-
profit organization where patients pay nominal charges
for consultation and treatment. The hospital equally ca-
ters to the urban as well as the rural population living in
the villages close to the city. The data used for this study
was drawn from a large data set, set up by the research
group, on the prescribing of antibiotics at this hospital.
Trained nursing staff collected the data on daily bases,
using a specific form attached to each patient file. The
data collection process has been described in detail
earlier [14].
Data management and analysis
Data was entered using Epi info (version 3.1) and Excel,
and the analyses were conducted using SPSS (version
21.0) and Stata (version 12.1), Texas, USA. The main
variable, prescribing of antibiotics, was analyzed separ-
ately for the group of women who had had a vaginal de-
livery and for the group of women that had had a
cesarean section. Descriptive statistics was performed to
calculate the total prescribed antibiotics in hospital and
at discharge, the mean number of days for which antibi-
otics were prescribed and prescribing by age group, place
of residence and days of stay in the hospital. A bivariate
and multivariable logistic regression was conducted for
the vaginal deliveries to study the association between the
binary outcome antibiotic prescriptions (yes, no) and the
following variables: age (18–20, 21–30, > = 31), place of
residence (Ujjain city, Nearby city, Villages of Ujjain
district, Other districts, Cities of the nearby district,
Other district villages) and days of stay in the hospital
(1–2, 3–5, >5). The term ‘OR’ has been used for the
Table 1 Overview of antibiotic prescribing among










prescriptions*a 491 (87) 503 (98)
Prescribed antibiotics
after discharge b 160 (28) 141 (28)
Age b
18-20 99 (17) 66 (13)
21-30 429 (76) 401 (78)
> = 31 38 (7) 44 (9)
Place of Residence b
Ujjain city 269 (48) 270 (53)
Nearby city 90 (16) 67 (13)
Villages of Ujjain district 81 (14) 60 (12)
Other districts 50 (9) 53 (10)
Cities of the nearby
district 32 (6) 25 (5)
Villages of other districts 44 (8) 36 (7)
Days of hospital stay +a
1-2 323 (57) 29 (6)
3-5 192 (34) 175 (34)
>5 51 (9) 307 (60)
Days on antibiotics** a 3.1 ± 1.74 6.0 ± 2.52
* number and percentages; Chi-Square test. **mean and standard deviations;
Kruskal-Wallis equality-of-populations rank test. aP-value < 0.05. bP-value > 0.05.
+Fisher’s exact test.
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ratio of multivariate logistic regressions in the text and
in the tables.
The Anatomical Therapeutic Chemical (ATC) classifi-
cation system and defined daily dose (DDD) was used to
classify the prescribed antibiotic [15]. The ATC system
divides the active substances into groups and subgroups
and the DDD is the assumed average maintenance dose
per day for a drug when used for its main indication in
adults. The DDD provides a fixed unit of measurement,
independent from e.g. strength and price, which enables
research on patterns in the prescribing of drugs. For this
study, the total DDD and DDD/100 bed days was used
to present the prescribing of antibiotics.
Ethical approval
The study was approved by the Ethics committee of R.D.
Gardi Medical College, Ujjain (41-2/2007).
Result
In total, 1077 women admitted to the VD Gardi Charit-
able Trust Hospital, who had delivered in the hospital;
either as vaginal delivery or cesarean section, were in-
cluded in the study. Of these 566 (53%) had a vaginal de-
livery and 511 (47%) had a cesarean section. In the
group of women who had a vaginal delivery 491 women
(87%) were prescribed antibiotics and in the group of
women who had a cesarean section 503 (98%) were pre-
scribed antibiotics in the hospital. The mean numbers of
days on antibiotics in hospital for women with a vaginal
delivery were 3.1 (±1.7) and for women with cesarean
section it was 6.0 (±2.5) (Table 1). Among women that
had a vaginal delivery, patients 31 years and above were
less likely [est. adj. OR = 0.31 (0.11-0.85); p-value 0.024]
than patients in the category 18–20 years (reference
group for variable age) to have been prescribed antibi-
otics during hospital stay or at discharge. The odds of
being prescribed antibiotics for women having a vaginal
delivery were three times lower [est. adj. OR = 0.31
(0.17-0.59); p-value <0.001] among residents in the cat-
egory ‘Nearby city’ compared to patients in the category
‘Ujjain City’(reference group for Residence variable). Fur-
ther, the group of women admitted to the hospital for
3–5 days were more likely to be prescribed antibiotics
[est. adj. OR = 2.22 (1.22; 4.02);p-value 0.009] than women
admitted 1–2 days. Statistical significance was not found
in among women with category of days of stay >5 (p-value
0.085) (Table 2).
The most commonly prescribed antibiotic groups dur-
ing the hospital stay among the women who had a vaginal
delivery were third generation cephalosporins (J01DD),
which were prescribed in 35% of the cases. This was
followed by a combinations of antibacterials (J01RA) pre-
scribed in 20% of the cases and penicillins with extendedspectrum (J01CA) prescribed in 15% of the cases. Among
the women who had a cesarean section, the most com-
monly prescribed antibiotic during the stay in hospital
was third-generation cephalosporins (J01DD) prescribed
in 31% of the cases, followed by the fixed dose combina-
tions of antibacterials (J01RA) prescribed in 30% of the
cases and fluoroquinolones (J01MA) prescribed in 13% of
the cases. The total DDD/100 bed days during hospital
stay for the group of women that had a vaginal delivery
was 101 and 127 for women having had a cesarean section
(Table 3).
Twenty-eight percent of the women with both vaginal
deliveries and with cesarean sections were prescribed anti-
biotics at discharge. The most commonly prescribed
group of antibiotic at discharge for women that had a va-
ginal delivery was fluoroquinolones (J01MA) prescribed in
42% of the cases, followed by second-generation cephalo-
sporins (J01DC) prescribed in 16% of the cases and peni-
cillins with extended spectrum (J01CA) prescribed in 14%
of the cases. Among the women that had a cesarean
section the most commonly prescribed antibiotics at
Table 2 Bivariate and multivariable logistic regression on antibiotics prescriptions among patients with vaginal
delivery (N = 566)
Bivariate Multivariable*
Characteristics OR (95% CI) p-value adj.OR (95% CI) p-value
Age 18-20 1
21-30 0.67 (0.32;1.4) 0.282 0.7 (0.33;1.49) 0.352
> = 31 0.28 (0.1;0.76) 0.012 0.31 (0.11;0.85) 0.024
Residence Ujjain city 1
Nearby city 0.33 (0.18;0.6) 0.001 0.31 (0.17;0.59) <0.001
Villages of Ujjain district 0.89 (0.4;1.98) 0.78 0.76 (0.34;1.71) 0.504
Other districts 0.82 (0.32;2.1) 0.676 0.8 (0.31;2.08) 0.644
Cities of the nearby district 0.78 (0.25;2.4) 0.665 0.81 (0.26;2.52) 0.72
Villages of other districts 0.71 (0.27;1.82) 0.473 0.71 (0.27;1.86) 0.487
Days of stay +a
1-2 1
3-5 2.07 (1.16;3.68) 0.014 2.22 (1.22;4.02) 0.009
>5 8.43 (1.14;62.6) 0.037 2.59 (0.88;7.66) 0.085
* adjusted by place of residence, age and duration of stay.
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59% of the cases, followed by third-generation cepha-
losporins (J01DC) prescribed in 11% of the cases and
second-generation cephalosporins (J01DC) and combi-
nations of penicillins, incl beta-lactamase inhibitors
(J01CR) prescribed in 9% of the cases each.
Discussion
Emerging antibiotic resistance is a major global public
health challenge. At the same time, untreated infections
are one of the main causes of maternal mortality in low
and middle-income countries [16]. In India, institutional
deliveries are being advocated to reduce the high burden
of maternal mortality and morbidity. Increased access to
basic and comprehensive emergency obstetric care
through the practice of routine institutional deliveries
can save the lives of many women, but increased use of
antibiotics can also add to the progressing antibiotic re-
sistance in India.
The topic of antibiotic use is not simple in the context
of India. It is likely that there is a widespread overuse of
antibiotics but also a challenge of antibiotics being un-
available when needed. Access to lifesaving antibiotics is
likely to be related to structural determinants of health.
The society is stratified by social determinants such as
economic status, caste and gender. Women from poor
socioeconomic households are less likely to have an in-
stitutional delivery or to receive postpartum care com-
pared to women belonging to a household with higher
socioeconomic status [17]. Women belonging to these
vulnerable groups are likely to be the main beneficiaries
of policy on increased coverage of institutional deliver-
ies. However, the same women are likely to be the firstto suffer from an increase in antibiotic resistance. New
antibiotics needed to meet the challenge of resistance
are often more expensive than the predecessor and this
is likely to increase the challenge for vulnerable groups
to afford treatment with antibiotics in a setting where
most maternal health care is paid out-of-pocket [18].
The results from this study show high rates of anti-
biotic prescribing for both women that had a vaginal de-
livery and women that had a cesarean section. In the
group of women who had a vaginal delivery 491 women
(87%) were prescribed antibiotics and in the group of
women who had a cesarean section 503 (98%t) were pre-
scribed antibiotics. As a comparison, resent figures from
the Christian Medical College (CMC) in Vellore, Tamil
Nadu, India showed that among women with a vaginal
delivery 22% were prescribed antibiotics and among
women having a cesarean section the most commonly
prescribed antibiotic was a single dose of cefazolin (Prof
S. Chandy, Christian Medical College, Vellore, personal
communication). The CMC, Vellore is, in resemblance
with the VD Gardi Charitable Trust Hospital, a non-
teaching, tertiary hospital that caters both rural and
urban population. One difference though is that the
CMC, has a general policy on antibiotic prescribing and
an active implementation of the policy since long. This
indicates that having a policy on antibiotic prescribing
and an active implementation of the policy can have an
impact on how antibiotics are prescribed also during de-
livery in hospitals, and can serve as an inspiration for
other hospitals in the Indian setting to develop and im-
plement such policy.
Women undergoing cesarean section have a five to
20-fold greater chance of getting an infection compared to
Table 3 Description of antibiotics prescribed during hospital stay and at discharge (N = 4721)
Vaginal Delivery Cesarean Section
N (%) Total DDD DDD/100 bed days N (%) Total DDD DDD/100 bed days
During hospital stay
ATC Name
Total 1496 (100) 1510 101 3225 (100) 4109 127
J01CA Penicillins with extended spectrum 226 (1) 140 62 46 (1) 35 77
J01CR Combinations of penicillins, incl
beta-lactamase inhibitors
109 (7) 144 132 272 (8) 440 162
J01DB 1st generation cephalosporins 35 (2) 14 41 44 (1) 23 51
J01DC 2nd generation cephalosporins 82 (5) 91 111 116 (4) 135 116
J01DD 3rd generation cephalosporins 525 (35) 628 120 988 (31) 1460 148
J01DH Carbapenems 4 (0.27) 2 50 3 (0.09) 3 100
J01EE Combinations of sulfonamides and
trimethoprim, incl derivatives 1 (0.07) 0 0 4 (0.12) 0.5 13
J01FA Macrolides 8 (0.53) 15 188 10 (0.31) 33 333
J01GB Other aminoglycosides 31 (2.) 18 59 233 (7) 199 86
J01MA Fluoroquinolones 173 (12) 214 124 430 (13) 709 165
J01RA Combinations of antibacterials 297 (20) 240 81 983 (30) 1013 103
J01XD Imidazole derivatives 5 (0.33) 3 60 96 (3) 58 60
At discharge
Total 425 (100) 151 952 (100) 153
J01CA Penicillins with extended spectrum 61 (14) 16
J01CR Combinations of penicillins, incl
beta-lactamase inhibitors
18 (4) 4 82 (9) 14
J01DB 1st generation cephalosporins 25 (6) 3 35 (4) 2
J01DC 2nd generation cephalosporins 66 (16) 32 82 (9) 12
J01DD 3rd generation cephalosporins 42 (10) 16 104 (11) 26
J01EE
Combinations of sulfonamides and
trimethoprim, incl derivatives 2 (0.47) 0.1 46 (5) 0.5
J01FA Macrolides 5 (1) 2
J01MA Fluoroquinolones 177 (42) 75 561 (59) 96
J01RA Combinations of antibacterials 29 (7) 3.2 42 (4) 2
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tibiotics at cesarean section reduces the risk of infection
[19]. In cesarean section, post-operative infections are likely
to be caused by Staphylococcus-epidermidis, Staphylococ-
cus aureus, Group B Streptococci or Enterococcus. The re-
sult from the study, showing that 98% of the women having
a cesarean section were prescribed antibiotics are therefore
not surprising and in line with WHO recommendation.
What the study shows, however, is that in the setting stud-
ied the type and dose of the prescribed antibiotics differs
from the recommendations made by the WHO. The WHO
recommends a single dose of cefazoline, a first generation
cephalosporin [20,21]. In the setting studied, third gener-
ation cephalosporins (J01DD) were prescribed in 30% of
the cases, followed by combinations of antibiotics (J01RA)
prescribed in 30% of the cases, and fluoroquinolones(J01MA) prescribed in 13% of the cases. Only 2% were pre-
scribed first generation cephalosporins. Data collected did
not allow analysis of when prophylactic antibiotics was pre-
scribed but the findings show that the mean number of
days on antibiotics prescribed during the hospital stay for
women with cesarean sections where 6.0 (±2.5), compared
to a single dose recommended by the WHO [22].
Additional studies are needed to better understand
the factors influencing the choice of type and dur-
ation of prophylactic antibiotics during cesarean sec-
tions in this setting.
High levels of antibiotics prescribed to women having
a vaginal delivery, both during hospital stay (87%) and at
discharge (28%), indicate that antibiotics are prescribed
for prophylactic purposes. Prophylactic use of antibiotics
during vaginal deliveries in the study setting is not well
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sented here. Studies from other settings show that in-
appropriate prescribing cannot always be explained by
lack information and/or knowledge. For example, a study
conducted in Lima showed a wide spread practice among
physicians to prescribe antibiotics for conditions that did
not require treatment with antibiotics despite having good
knowledge in terms of appropriate prescribing practices
[23]. Heavy workload, lack of information and feeling of
pressure to prescribe have been suggested to influence the
prescribing of antibiotics [24]. In the Indian setting factor
such as varied perceptions of the prescribers, distrust to-
wards the septic conditions of the health facilities and lack
of proper understanding of the maintaining asepsis might
contribute to high levels of prophylactic prescribing of an-
tibiotics. The factor influencing the choice of, on a routine
base, prescribe antibiotics for prophylactic purposes in the
setting of India needs to be further studied.
Assisted vaginal delivery is reported to increase the in-
cidence of postpartum infections [25-27]. To reduce the
risk of postpartum infections after an assisted vaginal
delivery, prophylactic antibiotics are often prescribed.
However, the benefits of such practice are not well stud-
ied. The few studies available have shown results that
both support [28,29] and dismiss [30,31] the use of anti-
biotics for prophylactic purposes and a Cochrane review
on this topic concludes that there are not enough evi-
dence to support the use of antibiotic prophylaxis for
operative vaginal delivery but that this needs to be care-
fully evaluated further [32]. The data collected for this
study does not provide information on how many of the
conducted vaginal deliveries that were assisted and fu-
ture studies needs to address assisted vaginal delivery in
addition to normal vaginal delivery and cesarean section.
Methodological considerations
One of the strength of this study is the detailed record
of prescribing data on individual patients throughout
their hospital stay. In addition, the data includes dis-
charge prescription. The data collection process, with
data collected daily by trained hospital staff, is an add-
itional strength. The topic of this study was multifaceted
and for this purpose the composition of the group of re-
searchers included competence in drug use, obstetrics,
statistics and policy science. The lack of data on socio-
economic status limits the possibilities of comparing
antibiotic prescriptions between different economic and
social classes. Lack of information on proportion of the
assisted or non-assisted vaginal deliveries is a further
weakness of the study.
Conclusions and Policy implications
High percentage of prescribing antibiotics in the pa-
tients having vaginal delivery and deviation from therecommendation for cesarean section in the hospital is
a cause of concern. The wide spread prescribing of
antibiotic to women having vaginal delivery also indi-
cates that antibiotics in this setting is routinely pre-
scribed for prophylactic purposes to women having
both normal as well as operative vaginal delivery. This
practice needs to be further studied, both in terms of
the benefits of prophylactic prescribing during assisted
vaginal deliveries and in terms of perceived benefits
among health personnel of prescribing antibiotics dur-
ing non-assisted vaginal delivery.
Improved maternal health and rational use of antibi-
otics are intertwined. The government of India is advo-
cating for institutional delivery as a strategy to reduce
maternal mortality. Following this strategy, there will be
a considerable increase in the number of inpatients in
the hospitals; this emphasizes the need of a specific pol-
icy on how and when to prescribe antibiotics during and
after delivery in healthcare facilities. Additionally, moni-
toring system of antibiotic prescribing and resistance
needs to be developed and implemented. As in most
cases of policy development and implementation, several
interventions are intertwined with each other. Policy on
prescribing of antibiotics needs to be linked to policy on
interventions on e.g. infection control such as hand hy-
giene and strengthening postpartum care where a large
proportion of infections occur.
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